Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.25USD
21 Sep 2018
Change (% chg)

$-0.58 (-5.36%)
Prev Close
$10.83
Open
$10.82
Day's High
$10.82
Day's Low
$10.25
Volume
153,772
Avg. Vol
35,863
52-wk High
$19.00
52-wk Low
$9.37

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  SPRO.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -- -- --
ROI: -- 1.79 14.61
ROE: -- 3.28 16.33

Earnings vs. Estimates